| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 5.06e-06 | 296 | 18 | 5 | GO:0015291 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 6.42e-06 | 41 | 18 | 3 | GO:0015175 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 5.05e-05 | 477 | 18 | 5 | GO:0022804 | |
| GeneOntologyMolecularFunction | transporter activity | 7.77e-05 | 1289 | 18 | 7 | GO:0005215 | |
| GeneOntologyMolecularFunction | alanine transmembrane transporter activity | 9.14e-05 | 16 | 18 | 2 | GO:0022858 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 1.09e-04 | 105 | 18 | 3 | GO:0015171 | |
| GeneOntologyMolecularFunction | antiporter activity | 2.44e-04 | 138 | 18 | 3 | GO:0015297 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 4.22e-04 | 1180 | 18 | 6 | GO:0022857 | |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 6.78e-04 | 43 | 18 | 2 | GO:0140828 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 1.84e-03 | 71 | 18 | 2 | GO:0015179 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 2.34e-03 | 301 | 18 | 3 | GO:0022853 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 2.50e-03 | 83 | 18 | 2 | GO:0015101 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 4.84e-03 | 793 | 18 | 4 | GO:0015075 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 7.89e-03 | 465 | 18 | 3 | GO:0046873 | |
| GeneOntologyMolecularFunction | symporter activity | 7.93e-03 | 150 | 18 | 2 | GO:0015293 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.02e-02 | 171 | 18 | 2 | GO:0015081 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 1.47e-02 | 207 | 18 | 2 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 1.48e-02 | 208 | 18 | 2 | GO:0005342 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 1.77e-02 | 627 | 18 | 3 | GO:0022890 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 2.06e-02 | 664 | 18 | 3 | GO:0008324 | |
| GeneOntologyBiologicalProcess | neutral amino acid transport | 1.85e-05 | 60 | 18 | 3 | GO:0015804 | |
| GeneOntologyBiologicalProcess | amino acid transmembrane transport | 1.47e-04 | 120 | 18 | 3 | GO:0003333 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 2.48e-05 | 736 | 13 | 6 | M27287 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 5.99e-05 | 249 | 13 | 4 | M5988 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 1.18e-04 | 108 | 13 | 3 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 1.22e-04 | 109 | 13 | 3 | MM15074 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 3.83e-04 | 32 | 13 | 2 | MM14957 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 4.08e-04 | 33 | 13 | 2 | M188 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 1.20e-03 | 238 | 13 | 3 | MM15076 | |
| Pathway | WP_PROXIMAL_TUBULE_TRANSPORT | 1.22e-03 | 57 | 13 | 2 | M39812 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 2.62e-03 | 84 | 13 | 2 | M27334 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 2.72e-03 | 681 | 13 | 4 | MM14985 | |
| Pubmed | 3.02e-05 | 16 | 18 | 2 | 35241668 | ||
| Pubmed | Amino acid transport across mammalian intestinal and renal epithelia. | 1.17e-04 | 31 | 18 | 2 | 18195088 | |
| Interaction | MS4A13 interactions | 2.41e-05 | 64 | 18 | 3 | int:MS4A13 | |
| Interaction | SLC30A2 interactions | 9.72e-05 | 102 | 18 | 3 | int:SLC30A2 | |
| Interaction | TRARG1 interactions | 1.25e-04 | 111 | 18 | 3 | int:TRARG1 | |
| GeneFamily | Solute carriers | 1.22e-05 | 395 | 15 | 5 | 752 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_DN | 8.90e-06 | 198 | 18 | 4 | M6516 | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.58e-05 | 145 | 18 | 3 | 47a3bb973a508d3097213a2d86ad1ce697af9bae | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.59e-05 | 162 | 18 | 3 | 10f7de4fb40ea9aee89bde3a280a82f6ccba2aeb | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic-Enterocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.68e-05 | 177 | 18 | 3 | 1f5b6498364b2017c4d49cd337d6e91c8e4f840d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.92e-05 | 180 | 18 | 3 | 1363b3254470f6ff98630d1df83a1bdbacc137e0 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.42e-05 | 186 | 18 | 3 | 8287146f0ba415ea04475588117d4668ae00f75c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.51e-05 | 187 | 18 | 3 | 71eb26ebf60cb0848e5bf1cd01edccda621aecd8 | |
| Drug | Prochlorperazine dimaleate [84-02-6]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 1.11e-05 | 182 | 18 | 4 | 5010_UP | |
| Drug | Cefoxitin sodium salt [33564-30-6]; Down 200; 8.8uM; HL60; HT_HG-U133A | 1.42e-05 | 194 | 18 | 4 | 2735_DN | |
| Drug | Prilocaine hydrochloride [1786-81-8]; Up 200; 15.6uM; HL60; HT_HG-U133A | 1.48e-05 | 196 | 18 | 4 | 2352_UP | |
| Drug | ST021200; Down 200; 10uM; MCF7; HT_HG-U133A | 1.54e-05 | 198 | 18 | 4 | 7488_DN | |
| Drug | Nifedipine [21829-25-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.61e-05 | 200 | 18 | 4 | 1692_UP | |
| Drug | alpha-Chlorohydrin | 5.94e-05 | 941 | 18 | 6 | ctd:D000517 | |
| Drug | Hydralazine | 2.85e-04 | 786 | 18 | 5 | ctd:D006830 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | 4.39e-04 | 192 | 18 | 3 | 2450_UP | |
| Drug | Syrosingopine [84-36-6]; Up 200; 6uM; MCF7; HT_HG-U133A | 4.39e-04 | 192 | 18 | 3 | 6213_UP | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 4.39e-04 | 192 | 18 | 3 | 6958_UP | |
| Drug | Galanthamine hydrobromide [1953-04-4]; Up 200; 10.8uM; HL60; HT_HG-U133A | 4.46e-04 | 193 | 18 | 3 | 2131_UP | |
| Drug | Idoxuridine [54-42-2]; Up 200; 11.2uM; PC3; HT_HG-U133A | 4.52e-04 | 194 | 18 | 3 | 4200_UP | |
| Drug | Thioguanosine [85-31-4]; Up 200; 12.6uM; HL60; HT_HG-U133A | 4.52e-04 | 194 | 18 | 3 | 1264_UP | |
| Drug | Dydrogesterone [152-62-5]; Down 200; 12.8uM; HL60; HT_HG-U133A | 4.59e-04 | 195 | 18 | 3 | 2156_DN | |
| Drug | Cyclizine hydrochloride [303-25-3]; Up 200; 13.2uM; HL60; HG-U133A | 4.59e-04 | 195 | 18 | 3 | 1731_UP | |
| Drug | estradiol, USP; Down 200; 0.01uM; ssMCF7; HG-U133A | 4.59e-04 | 195 | 18 | 3 | 414_DN | |
| Drug | Levamisole hydrochloride [16595-80-5]; Up 200; 16.6uM; HL60; HG-U133A | 4.59e-04 | 195 | 18 | 3 | 1410_UP | |
| Drug | Metrizamide [31112-62-6]; Down 200; 5uM; MCF7; HT_HG-U133A | 4.59e-04 | 195 | 18 | 3 | 4156_DN | |
| Drug | Diethylstilbestrol [56-53-1]; Down 200; 15uM; MCF7; HT_HG-U133A | 4.59e-04 | 195 | 18 | 3 | 4369_DN | |
| Drug | Dimaprit dihydrochloride [23256-33-9]; Down 200; 17uM; MCF7; HT_HG-U133A | 4.59e-04 | 195 | 18 | 3 | 7480_DN | |
| Drug | Rolipram [61413-54-5]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 4.59e-04 | 195 | 18 | 3 | 5330_UP | |
| Drug | (-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Up 200; 12.2uM; HL60; HT_HG-U133A | 4.66e-04 | 196 | 18 | 3 | 2969_UP | |
| Drug | Telenzepine dihydrochloride [147416-96-4]; Down 200; 9uM; HL60; HT_HG-U133A | 4.66e-04 | 196 | 18 | 3 | 2388_DN | |
| Drug | Lithocholic acid [434-13-9]; Down 200; 10.6uM; HL60; HT_HG-U133A | 4.66e-04 | 196 | 18 | 3 | 2571_DN | |
| Drug | Tetracycline hydrochloride [64-75-5]; Up 200; 8.4uM; PC3; HT_HG-U133A | 4.66e-04 | 196 | 18 | 3 | 2080_UP | |
| Drug | Buspirone hydrochloride [33386-08-2]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 4.66e-04 | 196 | 18 | 3 | 5343_UP | |
| Drug | Metyrapone [54-36-4]; Down 200; 17.6uM; HL60; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 3070_DN | |
| Drug | Ethamsylate [2624-44-4]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 7335_DN | |
| Drug | S(+)-Terguride [37686-84-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 5400_DN | |
| Drug | Fluoxetine hydrochloride [59333-67-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 3314_DN | |
| Drug | Sotalol hydrochloride [959-24-0]; Down 200; 13uM; PC3; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 4079_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; HL60; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 2674_UP | |
| Drug | raloxifene hydrochloride; Up 200; 0.1uM; HL60; HG-U133A | 4.73e-04 | 197 | 18 | 3 | 388_UP | |
| Drug | Atropine sulfate monohydrate [5908-99-6]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 2761_UP | |
| Drug | Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; HL60; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 2169_DN | |
| Drug | Gliquidone [33342-05-1]; Down 200; 7.6uM; HL60; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 3126_DN | |
| Drug | 9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A | 4.73e-04 | 197 | 18 | 3 | 7504_DN | |
| Drug | Nifurtimox [23256-30-6]; Down 200; 14uM; MCF7; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 7328_DN | |
| Drug | Oxamniquine [21738-42-1]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 7344_DN | |
| Drug | Sulfadimethoxine [122-11-2]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 3441_DN | |
| Drug | H-7 dihydrochloride; Up 200; 100uM; MCF7; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 5963_UP | |
| Drug | Antipyrine, 4-hydroxy [1672-63-5]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 4175_DN | |
| Drug | Isradipine [75695-93-1]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 6508_DN | |
| Drug | Trimethoprim [738-70-5]; Up 200; 13.8uM; HL60; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 2345_UP | |
| Drug | Todralazine hydrochloride [3778-76-5]; Up 200; 14.8uM; HL60; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 1841_UP | |
| Drug | alpha-estradiol; Down 200; 0.01uM; PC3; HG-U133A | 4.80e-04 | 198 | 18 | 3 | 702_DN | |
| Drug | (+,-)-Octopamine hydrochloride [770-05-8]; Down 200; 21uM; MCF7; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 5469_DN | |
| Drug | Theobromine [83-67-0]; Down 200; 22.2uM; HL60; HT_HG-U133A | 4.80e-04 | 198 | 18 | 3 | 2995_DN | |
| Drug | Terazosin hydrochloride [63590-64-7]; Down 200; 9.4uM; HL60; HT_HG-U133A | 4.87e-04 | 199 | 18 | 3 | 2530_DN | |
| Drug | Felbinac [5728-52-9]; Down 200; 18.8uM; HL60; HT_HG-U133A | 4.87e-04 | 199 | 18 | 3 | 3061_DN | |
| Drug | sulindac sulfone; Down 200; 50uM; MCF7; HG-U133A | 4.87e-04 | 199 | 18 | 3 | 314_DN | |
| Drug | SC-58125; Down 200; 10uM; MCF7; HG-U133A | 4.87e-04 | 199 | 18 | 3 | 254_DN | |
| Drug | Proparacaine hydrochloride [5875-06-9]; Down 200; 12uM; MCF7; HT_HG-U133A | 4.87e-04 | 199 | 18 | 3 | 6492_DN | |
| Drug | Cefmetazole sodium salt [56796-39-5]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 4.87e-04 | 199 | 18 | 3 | 6086_DN | |
| Drug | Coralyne chloride hydrate [38989-38-7]; Up 200; 9.6uM; PC3; HT_HG-U133A | 4.87e-04 | 199 | 18 | 3 | 6317_UP | |
| Drug | Delcorine; Down 200; 8.4uM; HL60; HT_HG-U133A | 4.87e-04 | 199 | 18 | 3 | 2178_DN | |
| Drug | Harpagoside [19210-12-9]; Down 200; 8uM; MCF7; HT_HG-U133A | 4.87e-04 | 199 | 18 | 3 | 7355_DN | |
| Drug | Isoflupredone acetate [338-98-7]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 4.87e-04 | 199 | 18 | 3 | 5545_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 50uM; MCF7; HG-U133A | 4.87e-04 | 199 | 18 | 3 | 348_DN | |
| Drug | azathioprine, USP; Down 200; 100uM; MCF7; HG-U133A | 4.94e-04 | 200 | 18 | 3 | 338_DN | |
| Drug | wortmannin from Penicillium funiculosum; Down 200; 0.01uM; MCF7; HT_HG-U133A | 4.94e-04 | 200 | 18 | 3 | 7002_DN | |
| Drug | Urosiol [128-13-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 4.94e-04 | 200 | 18 | 3 | 6484_DN | |
| Disease | 1-stearoyl-2-dihomo-linolenoyl-GPI (18:0/20:3n3 or 6) measurement | 2.83e-05 | 14 | 17 | 2 | EFO_0022085 | |
| Disease | lysophosphatidylethanolamine 20:4 measurement | 1.26e-04 | 29 | 17 | 2 | EFO_0010370 | |
| Disease | obsolete_red blood cell distribution width | 7.68e-04 | 1347 | 17 | 5 | EFO_0005192 | |
| Disease | phosphatidylinositol measurement | 1.35e-03 | 95 | 17 | 2 | EFO_0010230 | |
| Disease | omega-3 polyunsaturated fatty acid measurement | 2.07e-03 | 118 | 17 | 2 | EFO_0010119 | |
| Disease | unipolar depression | 4.31e-03 | 1206 | 17 | 4 | EFO_0003761 | |
| Disease | hippocampal volume | 1.24e-02 | 297 | 17 | 2 | EFO_0005035 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LIWTLLVVVGIGSVY | 66 | Q5QJU3 | |
| VNYITSWLSIVGPVV | 186 | Q9H0Y0 | |
| VIVVSVQIGLDTGYW | 1021 | P98198 | |
| LIVWIVTGFITVVGA | 76 | Q9UHI5 | |
| TVYTVLGILWGIIRE | 86 | Q9H2C8 | |
| WVVVGIVTAVVLGLT | 166 | O95297 | |
| ISITKGVIYIAVIWT | 181 | Q9NYM4 | |
| VLVVSVGVTWIVVSI | 11 | P98173 | |
| ILHIVITGIGWLYDV | 1161 | A4FU69 | |
| LVVVVVGGWTVVYLT | 6 | O43462 | |
| VIEFIYAIVGIVWLT | 106 | Q9Y4D2 | |
| VYEIGGLVPVWVVVV | 381 | Q6J4K2 | |
| WVYVVVVIVAGVPSL | 581 | Q695T7 | |
| WSYGPVILVVLVVAV | 216 | Q8NFQ8 | |
| TGWTLFVGVYIVIEI | 156 | P03923 | |
| LSVVGTWYVTAIVII | 206 | Q9NVC3 | |
| EVLGLIYAQTVVWVG | 531 | Q7Z404 | |
| SIWVVTGVLVYLAVE | 101 | Q9BRI3 | |
| CVVGTSLIWVIVIYH | 816 | O94898 |